2024-04-012025-03-312025-03-31false10570402PEARSONCLINIC LIMITED2025-07-15falseiso4217:GBPxbrli:pure105704022024-03-31105704022025-03-31105704022024-04-012025-03-31105704022023-03-31105704022024-03-31105704022023-04-012024-03-3110570402bus:SmallEntities2024-04-012025-03-3110570402bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3110570402bus:FullAccounts2024-04-012025-03-3110570402bus:PrivateLimitedCompanyLtd2024-04-012025-03-3110570402core:WithinOneYear2025-03-3110570402core:AfterOneYear2025-03-3110570402core:WithinOneYear2024-03-3110570402core:AfterOneYear2024-03-3110570402core:ShareCapital2025-03-3110570402core:SharePremium2025-03-3110570402core:RevaluationReserve2025-03-3110570402core:OtherReservesSubtotal2025-03-3110570402core:RetainedEarningsAccumulatedLosses2025-03-3110570402core:ShareCapital2024-03-3110570402core:SharePremium2024-03-3110570402core:RevaluationReserve2024-03-3110570402core:OtherReservesSubtotal2024-03-3110570402core:RetainedEarningsAccumulatedLosses2024-03-3110570402core:LandBuildings2025-03-3110570402core:PlantMachinery2025-03-3110570402core:Vehicles2025-03-3110570402core:FurnitureFittings2025-03-3110570402core:OfficeEquipment2025-03-3110570402core:NetGoodwill2025-03-3110570402core:IntangibleAssetsOtherThanGoodwill2025-03-3110570402core:ListedExchangeTraded2025-03-3110570402core:UnlistedNon-exchangeTraded2025-03-3110570402core:LandBuildings2024-03-3110570402core:PlantMachinery2024-03-3110570402core:Vehicles2024-03-3110570402core:FurnitureFittings2024-03-3110570402core:OfficeEquipment2024-03-3110570402core:NetGoodwill2024-03-3110570402core:IntangibleAssetsOtherThanGoodwill2024-03-3110570402core:ListedExchangeTraded2024-03-3110570402core:UnlistedNon-exchangeTraded2024-03-3110570402core:LandBuildings2024-04-012025-03-3110570402core:PlantMachinery2024-04-012025-03-3110570402core:Vehicles2024-04-012025-03-3110570402core:FurnitureFittings2024-04-012025-03-3110570402core:OfficeEquipment2024-04-012025-03-3110570402core:NetGoodwill2024-04-012025-03-3110570402core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110570402core:ListedExchangeTraded2024-04-012025-03-3110570402core:UnlistedNon-exchangeTraded2024-04-012025-03-3110570402core:MoreThanFiveYears2024-04-012025-03-3110570402core:Non-currentFinancialInstruments2025-03-3110570402core:Non-currentFinancialInstruments2024-03-3110570402dpl:CostSales2024-04-012025-03-3110570402dpl:DistributionCosts2024-04-012025-03-3110570402core:LandBuildings2024-04-012025-03-3110570402core:PlantMachinery2024-04-012025-03-3110570402core:Vehicles2024-04-012025-03-3110570402core:FurnitureFittings2024-04-012025-03-3110570402core:OfficeEquipment2024-04-012025-03-3110570402dpl:AdministrativeExpenses2024-04-012025-03-3110570402core:NetGoodwill2024-04-012025-03-3110570402core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110570402dpl:GroupUndertakings2024-04-012025-03-3110570402dpl:ParticipatingInterests2024-04-012025-03-3110570402dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110570402core:ListedExchangeTraded2024-04-012025-03-3110570402dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110570402core:UnlistedNon-exchangeTraded2024-04-012025-03-3110570402dpl:CostSales2023-04-012024-03-3110570402dpl:DistributionCosts2023-04-012024-03-3110570402core:LandBuildings2023-04-012024-03-3110570402core:PlantMachinery2023-04-012024-03-3110570402core:Vehicles2023-04-012024-03-3110570402core:FurnitureFittings2023-04-012024-03-3110570402core:OfficeEquipment2023-04-012024-03-3110570402dpl:AdministrativeExpenses2023-04-012024-03-3110570402core:NetGoodwill2023-04-012024-03-3110570402core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110570402dpl:GroupUndertakings2023-04-012024-03-3110570402dpl:ParticipatingInterests2023-04-012024-03-3110570402dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3110570402core:ListedExchangeTraded2023-04-012024-03-3110570402dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3110570402core:UnlistedNon-exchangeTraded2023-04-012024-03-3110570402core:NetGoodwill2025-03-3110570402core:IntangibleAssetsOtherThanGoodwill2025-03-3110570402core:LandBuildings2025-03-3110570402core:PlantMachinery2025-03-3110570402core:Vehicles2025-03-3110570402core:FurnitureFittings2025-03-3110570402core:OfficeEquipment2025-03-3110570402core:AfterOneYear2025-03-3110570402core:WithinOneYear2025-03-3110570402core:ListedExchangeTraded2025-03-3110570402core:UnlistedNon-exchangeTraded2025-03-3110570402core:ShareCapital2025-03-3110570402core:SharePremium2025-03-3110570402core:RevaluationReserve2025-03-3110570402core:OtherReservesSubtotal2025-03-3110570402core:RetainedEarningsAccumulatedLosses2025-03-3110570402core:NetGoodwill2024-03-3110570402core:IntangibleAssetsOtherThanGoodwill2024-03-3110570402core:LandBuildings2024-03-3110570402core:PlantMachinery2024-03-3110570402core:Vehicles2024-03-3110570402core:FurnitureFittings2024-03-3110570402core:OfficeEquipment2024-03-3110570402core:AfterOneYear2024-03-3110570402core:WithinOneYear2024-03-3110570402core:ListedExchangeTraded2024-03-3110570402core:UnlistedNon-exchangeTraded2024-03-3110570402core:ShareCapital2024-03-3110570402core:SharePremium2024-03-3110570402core:RevaluationReserve2024-03-3110570402core:OtherReservesSubtotal2024-03-3110570402core:RetainedEarningsAccumulatedLosses2024-03-3110570402core:NetGoodwill2023-03-3110570402core:IntangibleAssetsOtherThanGoodwill2023-03-3110570402core:LandBuildings2023-03-3110570402core:PlantMachinery2023-03-3110570402core:Vehicles2023-03-3110570402core:FurnitureFittings2023-03-3110570402core:OfficeEquipment2023-03-3110570402core:AfterOneYear2023-03-3110570402core:WithinOneYear2023-03-3110570402core:ListedExchangeTraded2023-03-3110570402core:UnlistedNon-exchangeTraded2023-03-3110570402core:ShareCapital2023-03-3110570402core:SharePremium2023-03-3110570402core:RevaluationReserve2023-03-3110570402core:OtherReservesSubtotal2023-03-3110570402core:RetainedEarningsAccumulatedLosses2023-03-3110570402core:AfterOneYear2024-04-012025-03-3110570402core:WithinOneYear2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110570402core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110570402core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110570402core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3110570402core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3110570402core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3110570402core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3110570402core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3110570402core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3110570402core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3110570402core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3110570402core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3110570402bus:Director12024-04-012025-03-3110570402bus:Director22024-04-012025-03-31

PEARSONCLINIC LIMITED

Registered Number
10570402
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

PEARSONCLINIC LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

PEARSON, Ian Christopher
PEARSON, Sarah Louise

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

10570402 (England and Wales)
PEARSONCLINIC LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3389247
389247
Current assets
Debtors46,6892,410
Cash at bank and on hand18,8828,747
25,57111,157
Creditors amounts falling due within one year5(12,900)(9,566)
Net current assets (liabilities)12,6711,591
Total assets less current liabilities13,0601,838
Net assets13,0601,838
Capital and reserves
Called up share capital150150
Profit and loss account12,9101,688
Shareholders' funds13,0601,838
The financial statements were approved and authorised for issue by the Board of Directors on 15 July 2025, and are signed on its behalf by:
PEARSON, Ian Christopher
Director
Registered Company No. 10570402
PEARSONCLINIC LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment50
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 241,0723551,427
Additions-395395
At 31 March 251,0727501,822
Depreciation and impairment
At 01 April 249302501,180
Charge for year36217253
At 31 March 259664671,433
Net book value
At 31 March 25106283389
At 31 March 24142105247
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables6,6892,410
Total6,6892,410
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables1,947585
Taxation and social security9,3815,149
Other creditors1941,973
Accrued liabilities and deferred income1,3781,859
Total12,9009,566